ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

[1]  G. Georgiou,et al.  Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth , 2016, Nature Medicine.

[2]  Mishal N. Patel,et al.  British Society of Breast Radiology Annual Scientific Meeting 2016 , 2016, Breast Cancer Research.

[3]  A. Gasbarrini,et al.  Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches , 2016, Journal of cellular physiology.

[4]  Tak W. Mak,et al.  The current state of cancer metabolism , 2016, Nature Reviews Cancer.

[5]  N. Hay,et al.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? , 2016, Nature Reviews Cancer.

[6]  Kyoung-Jae Won,et al.  AMPK–SKP2–CARM1 signalling cascade in transcriptional regulation of autophagy , 2016, Nature.

[7]  M. Nitti,et al.  Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy , 2016, Oxidative medicine and cellular longevity.

[8]  M. Santoro,et al.  ROS homeostasis and metabolism: a dangerous liason in cancer cells , 2016, Cell Death and Disease.

[9]  Christian M. Metallo,et al.  PGC1α drives a metabolic block on prostate cancer progression , 2016, Nature Cell Biology.

[10]  F. Sotgia,et al.  Cancer stem cell metabolism , 2016, Breast Cancer Research.

[11]  Xiaocui Wang,et al.  NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis , 2016, Science Translational Medicine.

[12]  Anneleen Daemen,et al.  mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. , 2016, Cancer cell.

[13]  E. Sokol,et al.  AMPK promotes tolerance to Ras pathway inhibition by activating autophagy , 2016, Oncogene.

[14]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[15]  R. Zhou,et al.  MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells , 2016, Oncotarget.

[16]  T. Yu,et al.  Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling , 2016, Journal of bone oncology.

[17]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[18]  G. Mills,et al.  Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines , 2015, International journal of oncology.

[19]  B. Viollet,et al.  AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis , 2015, Cell Death Discovery.

[20]  R. Deberardinis,et al.  PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth. , 2015, Molecular cell.

[21]  Alexey Sergushichev,et al.  Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. , 2015, Molecular cell.

[22]  M. Bergo,et al.  Antioxidants can increase melanoma metastasis in mice , 2015, Science Translational Medicine.

[23]  R. Deberardinis,et al.  Oxidative stress inhibits distant metastasis by human melanoma cells , 2015, Nature.

[24]  J. Velasco,et al.  Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer. , 2015, Free radical biology & medicine.

[25]  P. Urbánek,et al.  Redox regulation of FoxO transcription factors , 2015, Redox biology.

[26]  D. Hardie,et al.  AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. , 2015, Current opinion in cell biology.

[27]  Verena Albert,et al.  mTOR signaling in cellular and organismal energetics. , 2015, Current opinion in cell biology.

[28]  S. Inoue,et al.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. , 2015, Cancer cell.

[29]  F. Cecconi,et al.  Oxidative stress and autophagy: the clash between damage and metabolic needs , 2014, Cell Death and Differentiation.

[30]  G. Mills,et al.  Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect. , 2015, American journal of cancer research.

[31]  N. Ruderman,et al.  Insulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle. , 2014, Archives of biochemistry and biophysics.

[32]  N. Hay,et al.  The pentose phosphate pathway and cancer. , 2014, Trends in biochemical sciences.

[33]  Y. Liao,et al.  MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect , 2014, Oncogene.

[34]  D. Tuveson,et al.  The promise and perils of antioxidants for cancer patients. , 2014, The New England journal of medicine.

[35]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[36]  F. Viñals,et al.  Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) Is a Pro-survival, Endoplasmic Reticulum (ER) Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability* , 2014, The Journal of Biological Chemistry.

[37]  R. Muschel,et al.  Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  D. Sabatini,et al.  Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides , 2014, Nature.

[39]  Michael N. Hall,et al.  Making new contacts: the mTOR network in metabolism and signalling crosstalk , 2014, Nature Reviews Molecular Cell Biology.

[40]  G. Mills,et al.  Site-specific activation of AKT protects cells from death induced by glucose deprivation , 2014, Oncogene.

[41]  C. Rommel,et al.  PI3K and cancer: lessons, challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[42]  E. Larsson,et al.  Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.

[43]  F. Ross,et al.  Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells , 2014, The Biochemical journal.

[44]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[45]  J. Debnath,et al.  Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK , 2013, Oncogene.

[46]  Matija Snuderl,et al.  Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. , 2013, Cancer research.

[47]  P. Puigserver,et al.  PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. , 2013, Cancer cell.

[48]  Mohita Upadhyay,et al.  The Warburg effect: insights from the past decade. , 2013, Pharmacology & therapeutics.

[49]  A. Eijkelenboom,et al.  FOXOs: signalling integrators for homeostasis maintenance , 2013, Nature reviews. Molecular cell biology.

[50]  G. Filomeni,et al.  Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells , 2012, Autophagy.

[51]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[52]  T. Graeber,et al.  Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death , 2012, Molecular systems biology.

[53]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[54]  P. Ray,et al.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.

[55]  T. Mak,et al.  Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment , 2012, Proceedings of the National Academy of Sciences.

[56]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[57]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[58]  Yong‐Nyun Kim,et al.  Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.

[59]  Gordon B Mills,et al.  Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.

[60]  P. Sharma,et al.  A combination of 2-deoxy-d-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells , 2012, Tumor Biology.

[61]  P. Sorensen,et al.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis , 2011, Cell Death and Differentiation.

[62]  D. Tindall,et al.  Regulation of FOXO protein stability via ubiquitination and proteasome degradation. , 2011, Biochimica et biophysica acta.

[63]  Jason W Locasale,et al.  Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.

[64]  J. Liu,et al.  Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. , 2011, Gynecologic oncology.

[65]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[66]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[67]  D. Clemmons,et al.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. , 2011, Endocrinology.

[68]  G. Leclerc,et al.  AMPK and Akt Determine Apoptotic Cell Death following Perturbations of One-Carbon Metabolism by Regulating ER Stress in Acute Lymphoblastic Leukemia , 2011, Molecular Cancer Therapeutics.

[69]  O. Ilkayeva,et al.  Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells* , 2010, The Journal of Biological Chemistry.

[70]  G. Leclerc,et al.  AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia , 2010, Journal of molecular signaling.

[71]  D. Clemmons,et al.  AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. , 2010, Molecular endocrinology.

[72]  Sang Gyun Kim,et al.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. , 2010, Molecular cell.

[73]  C. Low,et al.  Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. , 2010, Current oncology.

[74]  C. Simone,et al.  The AMPK-FoxO3A axis as a target for cancer treatment , 2010, Cell cycle.

[75]  Mengwei Zang,et al.  AMPK exerts dual regulatory effects on the PI3K pathway , 2010, Journal of molecular signaling.

[76]  M. Pollak,et al.  Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells , 2010, Breast Cancer Research and Treatment.

[77]  R. Deberardinis,et al.  Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.

[78]  C. Simone,et al.  Inhibition of p38α unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism , 2009, Autophagy.

[79]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[80]  L. Harhaji-Trajković,et al.  AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells , 2009, Journal of cellular and molecular medicine.

[81]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[82]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[83]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[84]  K. Schulze-Osthoff,et al.  Switching Akt: from survival signaling to deadly response , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[85]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[86]  G. Ingravallo,et al.  p38α blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1α- to FoxO-dependent transcription , 2009, Cell Death and Differentiation.

[87]  A. Gormand,et al.  Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[88]  N. Hay,et al.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.

[89]  N. Hay,et al.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.

[90]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[91]  G. Semenza,et al.  Uterine DCs are essential for pregnancy. , 2008, The Journal of clinical investigation.

[92]  A. Marcus,et al.  2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition , 2008, Molecular Cancer Therapeutics.

[93]  J. Debnath,et al.  Induction of autophagy during extracellular matrix detachment promotes cell survival. , 2007, Molecular biology of the cell.

[94]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[95]  S. Gygi,et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.

[96]  Jonathan Pevsner,et al.  HIF-dependent antitumorigenic effect of antioxidants in vivo. , 2007, Cancer cell.

[97]  Steven L McKnight,et al.  Restriction of DNA Replication to the Reductive Phase of the Metabolic Cycle Protects Genome Integrity , 2007, Science.

[98]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[99]  A. Tzatsos,et al.  Energy Depletion Inhibits Phosphatidylinositol 3-Kinase/Akt Signaling and Induces Apoptosis via AMP-activated Protein Kinase-dependent Phosphorylation of IRS-1 at Ser-794* , 2007, Journal of Biological Chemistry.

[100]  N. Hay,et al.  The two TORCs and Akt. , 2007, Developmental cell.

[101]  D. Spitz,et al.  2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. , 2007, Cancer research.

[102]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[103]  E. White,et al.  Role of Autophagy in Cancer: Management of Metabolic Stress , 2007, Autophagy.

[104]  J. P. McCoy,et al.  The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.

[105]  L. Bertrand,et al.  AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. , 2006, American journal of physiology. Heart and circulatory physiology.

[106]  J. Dyck,et al.  Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. , 2006, American journal of physiology. Heart and circulatory physiology.

[107]  R. Jope,et al.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. , 2006, Biochemical pharmacology.

[108]  D. Vertommen,et al.  Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase α-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491* , 2006, Journal of Biological Chemistry.

[109]  M. Keleş,et al.  Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. , 2005, Cancer letters.

[110]  A. Fukamizu,et al.  Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Flanagan,et al.  Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. , 2005, The Journal of biological chemistry.

[112]  Y. Le Marchand-Brustel,et al.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. , 2005, Biochimie.

[113]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[114]  M. Guppy,et al.  Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.

[115]  M. Mueckler,et al.  Glucose transport and apoptosis , 2000, Apoptosis.

[116]  R. Medema,et al.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty , 2003, Journal of leukocyte biology.

[117]  D. Hardie,et al.  5′-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4-carboxamide Riboside* , 2001, The Journal of Biological Chemistry.

[118]  E. Kandel,et al.  Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.

[119]  Pier Paolo Pandolfi,et al.  The transcriptional role of PML and the nuclear body , 2000, Nature Cell Biology.

[120]  Y. Lee,et al.  Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. , 1999, Free radical biology & medicine.

[121]  P. Kuchel,et al.  Elevated glutamate dehydrogenase flux in glucose-deprived hybridoma and myeloma cells: evidence from 1H/15N NMR. , 1998, Biotechnology and bioengineering.

[122]  D. Spitz,et al.  Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[123]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[124]  J. Folkman,et al.  TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION , 1972, The Journal of experimental medicine.